Aquaporin A/S holds a unique and strong IP position in the field of biomimetic membrane materials.
The patent portfolio holds nine fully Aquaporin owned patent families and
one patent family jointly owned with Nanyang Technological University, Singapore.
Aquaporin A/S has three granted European patents and three granted US patents. In total, 61 patents have been granted so far worldwide, while 48 applications are still pending, including one international stage application.
The patent rights give protection on membrane design and incorporation of membranes in industrial standard form factors as well as unique systems and uses of the Aquaporin Inside™ technology in technical fields spanning from production of ultrapure water, diluted liquid fertilizer, treatment of industrial wastewater, generation of salinity power, and uses within hemodialysis and hemofiltration.
Our patent filing strategy is the highly useful combination of securing a fast national Danish patent right while pursuing international rights mainly through PCT applications, giving the company the possibility of obtaining patent rights in up to around 150 countries worldwide.
Aquaporin Inside™ and our logo are established trademarks registered in the EU and the USA as well as being pending in other important markets.